AI-generated summary
The authors report a randomized study of 60 patients with alopecia areata at Al-Azhar University Hospital comparing CO2 fractional laser plus daily Bimatoprost 0.03% against laser alone. The combination group had a higher response rate (80% vs. 40%), with minimal side effects reported. Limits include a single-center design with a modest sample and a need for larger, longer follow-up studies.
- Participants
- 60
- Who or what was studied
- Adults with clinically and dermoscopically confirmed alopecia areata at Al-Azhar University Hospital, enrolled January 2019 to May 2023.
- Limits stated in the abstract
- The authors note that larger sample sizes and longer follow-up are needed to validate the results and assess long-term sustainability.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.